Does the media prefer IART or SMA?

In the previous week, Integra LifeSciences and Integra LifeSciences both had 4 articles in the media. Integra LifeSciences' average media sentiment score of 0.76 beat Smartstop Self Storage REIT's score of 0.67 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smartstop Self Storage REIT 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ATRC or IART?

In the previous week, Integra LifeSciences had 3 more articles in the media than AtriCure. MarketBeat recorded 4 mentions for Integra LifeSciences and 1 mentions for AtriCure. Integra LifeSciences' average media sentiment score of 0.76 beat AtriCure's score of 0.50 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ANGO or IART?

In the previous week, Integra LifeSciences had 2 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for Integra LifeSciences and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.45 beat Integra LifeSciences' score of 0.76 indicating that AngioDynamics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integra LifeSciences 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Integra LifeSciences (IART) Competitors

$17.69 +0.09 (+0.51%)

Closing price 04:00 PM Eastern

Extended Trading

$17.69 0.00 (0.00%)

As of 07:09 PM Eastern

Compare

IART vs. ITGR, SMA, ATRC, ATEC, and ANGO

Should you buy Integra LifeSciences stock or one of its competitors? MarketBeat compares Integra LifeSciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Integra LifeSciences include Integer (ITGR), Smartstop Self Storage REIT (SMA), AtriCure (ATRC), Alphatec (ATEC), and AngioDynamics (ANGO). These companies are all part of the "health care equipment" industry.

How does Integra LifeSciences compare to Integer?

Integra LifeSciences (NASDAQ:IART) and Integer (NYSE:ITGR) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Integra LifeSciences presently has a consensus price target of $16.20, indicating a potential downside of 8.42%. Integer has a consensus price target of $98.71, indicating a potential upside of 10.36%. Given Integer's stronger consensus rating and higher probable upside, analysts plainly believe Integer is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27

Integra LifeSciences has a beta of 1.24, indicating that its share price is 24% more volatile than the broader market. Comparatively, Integer has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market.

84.8% of Integra LifeSciences shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 3.8% of Integra LifeSciences shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Integer has a net margin of 7.64% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
Integer	7.64%	12.83%	6.51%

In the previous week, Integra LifeSciences had 4 more articles in the media than Integer. MarketBeat recorded 4 mentions for Integra LifeSciences and 0 mentions for Integer. Integra LifeSciences' average media sentiment score of 0.76 beat Integer's score of 0.00 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Overall Sentiment
Integra LifeSciences	Positive
Integer	Neutral

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.84	-$516.47M	-$6.46	N/A
Integer	$1.85B	1.64	$102.81M	$4.01	22.31

Summary

Integer beats Integra LifeSciences on 11 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to Smartstop Self Storage REIT?

Integra LifeSciences (NASDAQ:IART) and Smartstop Self Storage REIT (NYSE:SMA) are both small-cap health care equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Integra LifeSciences currently has a consensus price target of $16.20, indicating a potential downside of 8.42%. Smartstop Self Storage REIT has a consensus price target of $36.81, indicating a potential upside of 13.27%. Given Smartstop Self Storage REIT's stronger consensus rating and higher possible upside, analysts plainly believe Smartstop Self Storage REIT is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.70

Smartstop Self Storage REIT has lower revenue, but higher earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.84	-$516.47M	-$6.46	N/A
Smartstop Self Storage REIT	$281.14M	6.40	-$1.55M	$0.15	216.67

84.8% of Integra LifeSciences shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by insiders. Comparatively, 5.5% of Smartstop Self Storage REIT shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Integra LifeSciences and Integra LifeSciences both had 4 articles in the media. Integra LifeSciences' average media sentiment score of 0.76 beat Smartstop Self Storage REIT's score of 0.67 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smartstop Self Storage REIT	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integra LifeSciences has a beta of 1.24, suggesting that its share price is 24% more volatile than the broader market. Comparatively, Smartstop Self Storage REIT has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market.

Smartstop Self Storage REIT has a net margin of 4.38% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Smartstop Self Storage REIT's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
Smartstop Self Storage REIT	4.38%	1.00%	0.54%

Summary

Smartstop Self Storage REIT beats Integra LifeSciences on 10 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to AtriCure?

AtriCure (NASDAQ:ATRC) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

AtriCure has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

In the previous week, Integra LifeSciences had 3 more articles in the media than AtriCure. MarketBeat recorded 4 mentions for Integra LifeSciences and 1 mentions for AtriCure. Integra LifeSciences' average media sentiment score of 0.76 beat AtriCure's score of 0.50 indicating that Integra LifeSciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure has a net margin of -0.83% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Integra LifeSciences	-30.15%	17.42%	5.00%

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are owned by institutional investors. 4.0% of AtriCure shares are owned by insiders. Comparatively, 3.8% of Integra LifeSciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

AtriCure presently has a consensus price target of $48.71, indicating a potential upside of 71.29%. Integra LifeSciences has a consensus price target of $16.20, indicating a potential downside of 8.42%. Given AtriCure's stronger consensus rating and higher probable upside, equities analysts plainly believe AtriCure is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Integra LifeSciences	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83

AtriCure has higher earnings, but lower revenue than Integra LifeSciences. AtriCure is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	2.69	-$11.45M	-$0.10	N/A
Integra LifeSciences	$1.64B	0.84	-$516.47M	-$6.46	N/A

Summary

AtriCure beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

How does Integra LifeSciences compare to Alphatec?

Integra LifeSciences (NASDAQ:IART) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends and valuation.

Integra LifeSciences currently has a consensus price target of $16.20, suggesting a potential downside of 8.42%. Alphatec has a consensus price target of $18.58, suggesting a potential upside of 118.63%. Given Alphatec's stronger consensus rating and higher possible upside, analysts clearly believe Alphatec is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

Alphatec has lower revenue, but higher earnings than Integra LifeSciences. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.84	-$516.47M	-$6.46	N/A
Alphatec	$764.16M	1.71	-$143.36M	-$0.82	N/A

In the previous week, Integra LifeSciences had 4 more articles in the media than Alphatec. MarketBeat recorded 4 mentions for Integra LifeSciences and 0 mentions for Alphatec. Integra LifeSciences' average media sentiment score of 0.76 beat Alphatec's score of 0.00 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Overall Sentiment
Integra LifeSciences	Positive
Alphatec	Neutral

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by company insiders. Comparatively, 13.5% of Alphatec shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Alphatec has a net margin of -15.93% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
Alphatec	-15.93%	-1,183.84%	-15.83%

Integra LifeSciences has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market. Comparatively, Alphatec has a beta of 0.88, meaning that its share price is 12% less volatile than the broader market.

Summary

Integra LifeSciences and Alphatec tied by winning 8 of the 16 factors compared between the two stocks.

How does Integra LifeSciences compare to AngioDynamics?

AngioDynamics (NASDAQ:ANGO) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

In the previous week, Integra LifeSciences had 2 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for Integra LifeSciences and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 1.45 beat Integra LifeSciences' score of 0.76 indicating that AngioDynamics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AngioDynamics has a net margin of -10.01% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-10.01%	-4.66%	-3.08%
Integra LifeSciences	-30.15%	17.42%	5.00%

AngioDynamics has higher earnings, but lower revenue than Integra LifeSciences. AngioDynamics is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$292.50M	1.75	-$33.99M	-$0.75	N/A
Integra LifeSciences	$1.64B	0.84	-$516.47M	-$6.46	N/A

AngioDynamics currently has a consensus price target of $18.67, suggesting a potential upside of 50.90%. Integra LifeSciences has a consensus price target of $16.20, suggesting a potential downside of 8.42%. Given AngioDynamics' stronger consensus rating and higher possible upside, research analysts clearly believe AngioDynamics is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
Integra LifeSciences	2 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.83

AngioDynamics has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market. Comparatively, Integra LifeSciences has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market.

89.4% of AngioDynamics shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 6.0% of AngioDynamics shares are held by insiders. Comparatively, 3.8% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

AngioDynamics beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IART vs. The Competition

Export

Metric	Integra LifeSciences	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.37B	$7.05B	$6.45B	$12.39B
Dividend Yield	N/A	1.28%	2.69%	5.83%
P/E Ratio	-2.74	40.00	21.07	22.20
Price / Sales	0.84	76.52	530.36	110.15
Price / Cash	4.17	24.78	44.82	54.51
Price / Book	1.32	7.13	10.79	6.50
Net Income	-$516.47M	$159.20M	$3.56B	$336.88M
7 Day Performance	-0.11%	-1.41%	1.67%	-0.22%
1 Month Performance	17.15%	-1.97%	0.43%	0.77%
1 Year Performance	52.24%	7.94%	32.84%	31.57%

Integra LifeSciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IART Integra LifeSciences	1.4741 of 5 stars	$17.69 +0.5%	$16.20 -8.4%	+51.7%	$1.37B	$1.64B	N/A	4,427	News Coverage
ITGR Integer	1.8805 of 5 stars	$90.67 +0.6%	$98.71 +8.9%	-23.7%	$3.08B	$1.86B	22.61	11,000	Positive News
SMA Smartstop Self Storage REIT	2.9823 of 5 stars	$33.09 +2.2%	$36.81 +11.3%	-11.1%	$1.83B	$281.14M	220.57	N/A
ATRC AtriCure	3.9626 of 5 stars	$28.41 -0.1%	$48.71 +71.4%	-9.4%	$1.44B	$534.53M	N/A	1,300
ATEC Alphatec	3.1422 of 5 stars	$8.60 +0.5%	$18.58 +116.2%	-21.8%	$1.32B	$764.16M	N/A	700

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IART) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integra LifeSciences (IART) Competitors

IART vs. ITGR, SMA, ATRC, ATEC, and ANGO

How does Integra LifeSciences compare to Integer?

Summary

How does Integra LifeSciences compare to Smartstop Self Storage REIT?

Summary

How does Integra LifeSciences compare to AtriCure?

Summary

How does Integra LifeSciences compare to Alphatec?

Summary

How does Integra LifeSciences compare to AngioDynamics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integra LifeSciences (IART) Competitors

IART vs. ITGR, SMA, ATRC, ATEC, and ANGO

How does Integra LifeSciences compare to Integer?

Do analysts recommend IART or ITGR?

Which has more risk and volatility, IART or ITGR?

Do insiders & institutionals have more ownership in IART or ITGR?

Is IART or ITGR more profitable?

Does the media prefer IART or ITGR?

Which has higher earnings and valuation, IART or ITGR?

Summary

How does Integra LifeSciences compare to Smartstop Self Storage REIT?

Do analysts rate IART or SMA?

Which has preferable earnings and valuation, IART or SMA?

Do institutionals & insiders believe in IART or SMA?

Does the media prefer IART or SMA?

Which has more volatility and risk, IART or SMA?

Is IART or SMA more profitable?

Summary

How does Integra LifeSciences compare to AtriCure?

Which has more risk & volatility, ATRC or IART?

Does the media prefer ATRC or IART?

Is ATRC or IART more profitable?

Do institutionals & insiders believe in ATRC or IART?

Do analysts prefer ATRC or IART?

Which has stronger valuation & earnings, ATRC or IART?

Summary

How does Integra LifeSciences compare to Alphatec?

Do analysts recommend IART or ATEC?

Which has preferable earnings & valuation, IART or ATEC?

Does the media favor IART or ATEC?

Do institutionals & insiders hold more shares of IART or ATEC?

Is IART or ATEC more profitable?

Which has more volatility & risk, IART or ATEC?

Summary

How does Integra LifeSciences compare to AngioDynamics?

Does the media prefer ANGO or IART?

Is ANGO or IART more profitable?

Which has preferable valuation & earnings, ANGO or IART?

Do analysts recommend ANGO or IART?

Which has more volatility and risk, ANGO or IART?

Do institutionals and insiders hold more shares of ANGO or IART?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IART vs. The Competition

Integra LifeSciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools